Drug Type Synthetic peptide |
Synonyms Detirelix acetate (USAN), RS-68439 |
Target |
Action antagonists |
Mechanism GnRHR antagonists(Gonadotropin-releasing hormone receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC80H109ClN18O15 |
InChIKeyLYJZZIGNRVWHHS-ZHFMCWKGSA-N |
CAS Registry102583-46-0 |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D03701 | - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Contraception | Phase 1 | - | - |
Phase 4 | - | - | gonadotropin-releasing hormone antagonist (Midfollicular phase) | rkxpitrgop(uxgqgvuwxs) = ftnqntknri ulbdbvcnrc (tpootvmsmi ) View more | - | 01 Apr 1991 | |
gonadotropin-releasing hormone antagonist (Preovulatory phase) | rkxpitrgop(uxgqgvuwxs) = xpzoelhxde ulbdbvcnrc (tpootvmsmi ) |






